期刊文献+

缺血性脑卒中的危险因素研究进展 被引量:1

下载PDF
导出
摘要 缺血性脑卒中(ICVD)的传统危险因素日益受到人们的重视,除了已知因素(高血压、吸烟饮酒、糖尿病、肥胖、高脂血症、高盐饮食、药物滥用、血液病及血液流变学异常等)导致的血栓前状态或血黏度增加外,近几年又逐步认识到一些新的ICVD危险因素,现就其研究进行简要回顾。
出处 《实用心脑肺血管病杂志》 2006年第7期591-592,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
  • 相关文献

参考文献11

  • 1Elkind MS,Lin IF,GraystonJ JT,et al.Chlamydia pneumoniae and the risk of first ischemic strok:The Northern Manhattan Stroke[J].Study Stroke,2000,31:1521-1525.
  • 2Tamacka B,Gromadzka G,Czlonkowska A,et al.Increased circulating immune complexes in acute stroke:the triggering role of Chlamydia pneumoniae and cytomegalovrius[J].Stroke,2002,33:936-940.
  • 3Markus HS,Mendall MA.Helicobacter pylori infection:a risk factor for ischaemic cerebrovascular disease and crarotid atheroma[J].J Neurol Neurosurg PSYchiatry,1998,64:104-107.
  • 4Moolenaar WH.Lysophosphatidic acid,a multifunctional phos2 pholipid messenger[J].J Biol Chem,1995,270:12949 -12952.
  • 5黄世昌,伍期专.溶血磷脂酸与缺血性(心)脑卒中[J].基础医学与临床,2003,23(1):1-4. 被引量:23
  • 6Li W,Tian Y,Feng H,et al.Effects of taurine and extraction of cristata Lon serum Zn,Cu and Ca in rats[J].Wei-Sheng-Yan-Jiu,1998,27:341-343.
  • 7Elis A,Froom P,Ninio A,et al.Employe exposure to chromjum and plasma lipid oxidation[J].Int J Occup Environ Health,2002,7:206-208.
  • 8Venter HD,Tang Q,Liu Q,et al.A new mechanism of neurodegeneration:a proinflammatory cytokine inhibits receptor signaling by a survival peptide[J].Proc Natl ACAD Sci USA,1999,96:9879-9884.
  • 9杨放如,李家邦.心身放松疗法对高血压患者血压及生活质量的影响[J].中国全科医学,2005,8(9):731-733. 被引量:17
  • 10Bots ML,Launer LJ,Lindemans J,Hoes AW,et al.Homocysteine and short-term risk of myocardial infarction and stroke in the elderly:the Rotterdam Study[J].Arch Intern Med,1999,159:38-44.

二级参考文献40

  • 1陈丽,成猛.浅谈社区高血压的综合康复治疗[J].中国全科医学,2004,7(24):1851-1852. 被引量:30
  • 2McQuillan BM, Beilby JP, Nidorf M, et al. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
  • 3Vermeulen EG, Rauwerda JA, van den Berg M, et al. Homocysteinelowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-point
  • 4van Dijk RA, Rauwerda JA, Steyn M, et al. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stif
  • 5Vermeulen EG, Niessen HW, Bogels M, et al. Decreased smooth muscle cell/extracellular matrix ratio of media of femoral artery in patients with atherosclerosis and hyperhomocysteinemia. Arterioscler Thromb Vasc Biol, 2001, 21:573 -577.
  • 6Kristensen B, Malm J, Nilsson TK, et al. Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke, 1999,30:974 - 980.
  • 7Selhub J. Homocysteine metabolism. Annu Rev Nutr, 1999, 19:217 -246.
  • 8Yoo JH, Chung CS, Kang SS. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke, 1998, 29:2478 - 2483.
  • 9Ray JG, Harvey DT. Hyperhomocysteinemia as a cause of premature stroke in a young patient. Arch Phys Med Rehabil, 1998, 79:343 - 345.
  • 10Tan NC, Venketasubramanian N, Saw SM, et al. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.Stroke, 2002, 33:1956 - 1962.

共引文献43

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部